Navigation Links
Isis Reports Follow-Up Data From ISIS-SMN Rx Phase 1 Study In Children With Spinal Muscular Atrophy
Date:9/19/2013

in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2012, and its most recent quarterly report on Form 10-Q, which are on file with the SEC. Copies of these and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries.

Isis Pharmaceuticals® is a registered trademark of Isis Pharmaceuticals, Inc.  KYNAMRO™ is a trademark of Genzyme Corporation.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
3. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
4. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
7. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
8. Luminex Corporation Reports First Quarter 2012 Results
9. Hospira Reports First-Quarter 2012 Results
10. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
11. The Female Health Company Reports Second Quarter Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... 2015 Research and Markets ... "Stability Testing of Pharmaceuticals (London, UK - December ... By attending this comprehensive two day seminar delegates will: ... studies that are suitable for global arketing - ... manage stability samples and facilities - Know how ...
(Date:9/4/2015)... and MENLO PARK, Calif. , ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company ... therapies, today announced its financial results for the fiscal ... of recent Company highlights and expected near-term milestones. ... update conference call and live webcast for investors, analysts ...
(Date:9/3/2015)... Sept. 3, 2015  Cipla, a global pharmaceutical company ... needs of all patients, today announced that its UK ... acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan ... conditions, is valued at $550 million and will be ... transactions is over $200 million for the year ended ...
Breaking Medicine Technology:Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5
... Masimo (NASDAQ: MASI ) ... month,s issue of the peer-reviewed journal, Annals of ... measurements provide an "effective means for screening at-risk populations ... to invasive blood gas analysis.  The prospective diagnostic accuracy ...
... Sanare, LLC, a leading provider of care ... new consumer brand, BrightSky, have become National Strategic ... (Logo: http://photos.prnewswire.com/prnh/20110414/FL83264LOGO) The sponsorship makes Sanare ... Association,s newly diagnosed patient initiative called "Living With ...
Cached Medicine Technology:New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 2New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 3New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 4New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 5New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 6Sanare and BrightSky Announce National Strategic Partnership with American Diabetes Association 2
(Date:9/4/2015)... ... September 04, 2015 , ... The Schmidt National Law Group filed an ... , Schmidt National Law Group, a leading firm in mass-tort litigation, has filed ... Corp., Bayer Essure, Inc., and other Bayer affiliates for injuries alleged to have been ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... communities, is launching a charity effort to provide for the family of Grace, ... an enlarged heart, restrictive cardiomyopathy often leads to diastolic dysfunction – the inability ...
(Date:9/4/2015)... ... September 04, 2015 , ... A Union County charitable organization ... Compassion Project is a non-profit organization dedicated to offering Pilates scholarships to cancer ... treatments and recover their mobility, strength, and range of motion following breast cancer ...
(Date:9/4/2015)... Francisco, CA (PRWEB) , ... September 04, 2015 ... ... Amini, announces that CEREC technology is now available at CitiDent. CEREC is a ... machinery. In addition to saving time for patients by eliminating the need for ...
(Date:9/4/2015)... ... September 04, 2015 , ... Many consumers are looking for a quick and convenient way ... , The patent-pending K Med Cups provide a quick and simple way to brew a ... cold, flu or cough. As a result, they enhance comfort and health. The invention features ...
Breaking Medicine News(10 mins):Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2
... Durable Medical Equipment Providers Out of,Business and Disrupt Services ... Area, ARLINGTON, Va., April 7, 2008 A ... to be,implemented in the Charlotte, Gastonia, and Concord areas ... DME providers out of business and could,disrupt services for ...
... Albemarle,Corporation (NYSE: ALB ) will hold its quarterly conference ... at 9:00am ET., This call is being webcast by ... http://www.albemarle.com in the Investor,Information section., ... Dial In # 800-591-6942 International ...
... Individuals With,Schizophrenia and Families Together for a Comprehensive ... April 7 The process of,recovering from severe ... not Destiny, to be held April 12-13, 2008 ... DC. We invite you to contact,us to learn ...
... DANVILLE, PA Using the Electronic Health Record to ... in improved blood sugar and cholesterol levels, better vaccination ... new Geisinger study. , Geisinger Health System launched ... diabetes patients in 2005. A study published in Aprils ...
... New York Hospital Upgrades Three X-Ray Rooms from Film to IDC ... ... April 7 /PRNewswire-FirstCall/ - IDC (Imaging Dynamics Company,Ltd.) (TSX: IDL), the ... that Saratoga Hospital in Saratoga,Springs, New York has purchased IDC,s X2200, ...
... on April 25th, Suracell Inc. urges Americans to use ... their genes to promote healthy aging, SOUTH ORANGE, N.J., ... on everything touted as "good for you?" Convinced,there,s nothing you can do ... in personal genetic health. With National DNA,Day on April 25, Suracell is ...
Cached Medicine News:Health News:Medicare Bidding Program for Charlotte, N.C. is Plagued by Errors, Says American Association for Homecare 2Health News:Medicare Bidding Program for Charlotte, N.C. is Plagued by Errors, Says American Association for Homecare 3Health News:Albemarle Corporation's First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 9:00am ET 2Health News:Schizophrenia: Diagnosis Is Not Destiny - Conference 2Health News:Geisinger improves care for thousands of diabetics through use of the Electronic Health Record 2Health News:Saratoga Hospital Purchases Three IDC DR Systems 2Health News:Saratoga Hospital Purchases Three IDC DR Systems 3Health News:Know Your Personal Genetic Health to Age Better Now! 2
... The mobile universal operating table for ... top allows for unlimited C-arm access. ... for both neurosurgical and cardiovascular procedures. ... for floor support can easily be ...
... the Cmax operating table that combines all ... table with the radiolucence and precise mobility ... most advanced, versatile surgical table on the ... support advancements in surgical procedures and imaging ...
... Table offers complete imaging access, with nearly ... and mobile imaging C-Arms can pan from ... reposition the patient. Anesthesiologists will appreciate this ... drive, quality construction, and ease of operation. ...
...
Medicine Products: